| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |